Correction to “circRNA-SORE/UBQLN1/GPX4 Mediates the Acquisition of Sorafenib Resistance in Hepatocellular Carcinoma Through Inhibition of Ferroptosis”

doi:10.1002/mco2.70703

MedComm ›› 2026, Vol. 7 ›› Issue (4) :e70703 DOI: 10.1002/mco2.70703

CORRECTION

Correction to “circRNA-SORE/UBQLN1/GPX4 Mediates the Acquisition of Sorafenib Resistance in Hepatocellular Carcinoma Through Inhibition of Ferroptosis”

Author information +

History +

PDF (204KB)

Abstract

L. Ji, Y. Ruan, M. Tong, et al., “circRNA-SORE/UBQLN1/GPX4 Mediates the Acquisition of Sorafenib Resistance in Hepatocellular Carcinoma Through Inhibition of Ferroptosis,” MedComm 6, no. 12 (2025): e70488.

In figure 4, the result shown in H was mistakenly used. We updated it with the correct result.

We apologize for this error.

Cite this article

Download citation ▾

null. Correction to “circRNA-SORE/UBQLN1/GPX4 Mediates the Acquisition of Sorafenib Resistance in Hepatocellular Carcinoma Through Inhibition of Ferroptosis”. MedComm, 2026, 7 (4) : e70703 DOI:10.1002/mco2.70703

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

RIGHTS & PERMISSIONS

2026 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.